Regarding other mental diseases, while TGFB2 was the highest-ranked risk gene in a deep post-GWAS analysis of AD patients [42], its increased expression has been reported in post-mortem brains of patients with AD [42,43]. This evidence concerns the gene TGFB2 and Alzheimer disease.